Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 30: 1523-1532, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehrlich, P. H.
Right arrow Articles by Moyle, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehrlich, P. H.
Right arrow Articles by Moyle, W. R.

Clinical Chemistry, Vol 30, 1523-1532, Copyright © 1984 by American Association for Clinical Chemistry

Specificity considerations in cooperative immunoassays

PH Ehrlich and WR Moyle

Mixtures of some monoclonal antibodies form circular antibody-antigen complexes, which facilitates their ability to bind antigen. This effect forms the basis of a potentially very sensitive assay procedure, the cooperative immunoassay (CIA). Unlike other immunoassays, in which binding can be characterized by a simple "binding constant," the binding of antigen by two antibodies in a CIA depends on several binding parameters, including the affinity of each antibody for antigen as well as the tendency of the reactants to form a circular complex. The ability of the CIA to distinguish between two similar molecules depends on the relative affinity of the antibodies for each antigen and on the ability of the antigens to participate in forming a circular complex. To study the binding of antibody mixtures to cross-reacting antigens, we devised a mathematical model to account for all possible antibody-antigen complexes, including those composed of circular complexes; however, we limited this model to the case in which one antibody was adsorbed to a solid phase. We illustrate here both theoretically and experimentally that a mixture of two antibodies in a CIA may have increased or decreased specificity, if circular complexes containing one or two molecules of cross-reacting antigen are formed. We discuss simple practical considerations that can help optimize specificity and sensitivity of solid-phase assays involving two monoclonal antibodies.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.